Endocannabinoid release at ventral hippocampal-amygdala synapses regulates stress-induced behavioral adaptation

Cell Rep. 2023 Sep 26;42(9):113027. doi: 10.1016/j.celrep.2023.113027. Epub 2023 Sep 12.

Abstract

The endocannabinoid (eCB) system is a key modulator of glutamate release within limbic neurocircuitry and thus heavily modulates stress responsivity and adaptation. The ventral hippocampus (vHPC)-basolateral amygdala (BLA) circuit has been implicated in the expression of negative affective states following stress exposure and is modulated by retrograde eCB signaling. However, the mechanisms governing eCB release and the causal relationship between vHPC-BLA eCB signaling and stress-induced behavioral adaptations are not known. Here, we utilized in vivo optogenetic- and biosensor-based approaches to determine the temporal dynamics of activity-dependent and stress-induced eCB release at vHPC-BLA synapses. Furthermore, we demonstrate that genetic deletion of cannabinoid type-1 receptors selectively at vHPC-BLA synapses decreases active stress coping and exacerbates stress-induced avoidance and anhedonia phenotypes. These data establish the in vivo determinants of eCB release at limbic synapses and demonstrate that eCB signaling within vHPC-BLA circuitry serves to counteract adverse behavioral consequences of stress.

Keywords: 2-arachidonoylglycerol; CB1 receptor; CP: Neuroscience; anhedonia; anxiety; cannabinoid; cannabis; depression; posttraumatic stress disorder; resilience.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Amygdala / physiology
  • Basolateral Nuclear Complex* / metabolism
  • Endocannabinoids* / metabolism
  • Hippocampus / metabolism
  • Receptor, Cannabinoid, CB1 / genetics
  • Receptor, Cannabinoid, CB1 / metabolism
  • Receptors, Cannabinoid
  • Synapses / metabolism

Substances

  • Endocannabinoids
  • Receptors, Cannabinoid
  • Receptor, Cannabinoid, CB1